NeurologyLive® Friday 5 — August 7, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Understanding the Gut-Brain Connection in Parkinson Disease: Laurie Sanders, PhD

In a recent interview, Laurie Sanders, PhD, associate professor of neurology at Duke University School of Medicine, discussed a multicenter initiative studying gut-brain communication in Parkinson disease. [WATCH TIME: 4 minutes]

2: Weighing Disease-Modifying Therapy Discontinuation in Older, Stable Patients With MS

In a recent Q&A interview at CMSC 2026, John Corboy, MD, professor of neurology at the University of Colorado, discussed recent findings focused on disease-modifying therapy discontinuation in older, stable patients with multiple sclerosis.

3: The Future of Alzheimer Disease Care: Toward Biomarker-Guided Personalized Treatment

As research expands beyond amyloid and tau, NYU Langone Health experts Allal Boutajangout, PhD, and Thomas Wisniewski, MD, discuss how novel biomarkers could identify multiple coexisting neurodegenerative pathologies and pave the way for more personalized treatment approaches based on each patient’s unique disease profile. [WATCH TIME: 9 Minutes]

4: NeuroVoices: Brian Callaghan, MD, on Recapping the 2026 Peripheral Nerve Society Annual Meeting

In our latest NeuroVoices Q&A, Brian Callaghan, MD, associate professor at the University of Michigan covered the 2026 Peripheral Nerve Society Annual Meeting, highlighting emerging themes in GBS, SMA, TTR neuropathy, RFC1, and what is still keeping the field up at night.

5: Behind Synapticure’s Newly Expanded Virtual Ataxia Care Program

In a recent Q&A, Elizabeth Ferluga, MD, and Kristen Fortino, discuss a newly launched virtual care program, the barriers facing patients with ataxia, and the potential for remote access to specialized care to improve diagnosis, treatment, and clinical trial connectivity.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!